Cytek Biosciences Ownership | Who Owns Cytek Biosciences?

Overview RevenueFinancials Chart Transcripts

Cytek Biosciences Ownership Summary

Cytek Biosciences is owned by 58.96% institutional investors, 8.94% insiders, and 32.10% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.11% of CTKB shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.16% of its assets in Cytek Biosciences shares.

CTKB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cytek Biosciences	58.96%	8.94%	32.10%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Medical Device Stocks	40.18%	9.93%	49.89%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	18.48M	14.11%	$119.95M
Blackrock	17.07M	13.04%	$95.25M
Vanguard group	11.72M	8.94%	$76.04M
Brown capital management	8.25M	6.29%	$53.52M
Hhlr advisors	6.66M	5.08%	$43.20M
State street	4.51M	3.44%	$29.27M
Geode capital management	2.64M	2.01%	$17.13M
New york state common retirement fund	2.09M	1.59%	$13.55M
Dimensional fund advisors lp	1.83M	1.40%	$11.88M
Wellington management group llp	1.52M	1.16%	$9.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Hhlr advisors	6.66M	1.50%	$43.20M
Brown capital management	8.25M	1.24%	$53.52M
Topline capital management	236.60K	0.29%	$1.54M
Olympiad research lp	19.60K	0.13%	$127.21K
Sherbrooke park advisers	41.77K	0.09%	$271.11K
Algert global	350.92K	0.05%	$2.28M
Versor investments lp	47.00K	0.05%	$305.03K
Dark forest capital management lp	49.85K	0.05%	$323.51K
Globeflex capital l p	84.43K	0.05%	$547.98K
State of wyoming	39.77K	0.03%	$258.12K

Top Buyers

Holder	Shares	% Assets	Change
Ubs group	665.73K	0.00%	646.79K
Millennium management	803.92K	0.00%	613.31K
Point72 asset management	389.36K	0.01%	389.36K
Jpmorgan chase	947.68K	0.00%	349.15K
State street	4.51M	0.00%	342.88K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-6.81M
Brown capital management	8.25M	1.24%	-1.25M
Fil	-	-	-573.60K
Wellington management group llp	1.52M	0.00%	-489.93K
Divisadero street capital management, lp	-	-	-487.55K

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	389.36K	0.01%	389.36K	$2.53M
Topline capital management	236.60K	0.29%	236.60K	$1.54M
Bnp paribas arbitrage, snc	208.66K	0.00%	208.66K	$1.35M
Panagora asset management	127.00K	0.00%	127.00K	$824.22K
Raymond james financial	117.87K	0.00%	117.87K	$764.98K

Sold Out

Holder	Change
Capital performance advisors llp	-12.00
Mendota financial group	-13.00
Nelson, van denburg & campbell wealth management group	-24.00
Huntington national bank	-36.00
Quest partners	-68.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	150	11.11%	77,235,970	3.02%	58	1.80%	89	3.49%	40	29.03%
Sep 30, 2024	135	5.47%	74,969,791	-1.57%	57	1.70%	86	13.16%	31	-22.50%
Jun 30, 2024	126	3.28%	76,150,225	-5.51%	58	1.64%	75	17.19%	40	14.29%
Mar 31, 2024	122	19.61%	80,592,474	2.10%	59	1.77%	64	12.28%	35	16.67%
Dec 31, 2023	102	-5.56%	78,933,920	1.89%	57	1.78%	57	-20.83%	30	30.43%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	6.61M	5.16%	4.58K
Vanguard Total Stock Mkt Idx Inv	3.37M	2.63%	-
iShares Russell 2000 ETF	3.18M	2.48%	-27.55K
Vanguard Small Cap Index	2.63M	2.05%	2.14K
Brown Capital Mgmt Small Co Inv	2.43M	1.89%	-1.46M
Vanguard Institutional Extnd Mkt Idx Tr	1.59M	1.24%	2.65K
Vanguard Small Cap Growth Index Inv	1.48M	1.15%	-5.69K
Fidelity Small Cap Index	1.19M	0.93%	-22.26K
iShares Russell 2000 Value ETF	1.09M	0.85%	-
iShares S&P Small-Cap 600 Value ETF	1.06M	0.83%	-1.05K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	3
2024 Q1	-	2

CTKB Ownership FAQ

Who Owns Cytek Biosciences?

Cytek Biosciences shareholders are primarily institutional investors at 58.96%, followed by 8.94% insiders and 32.10% retail investors. The average institutional ownership in Cytek Biosciences's industry, Medical Device Stocks, is 40.18%, which Cytek Biosciences exceeds.

Who owns the most shares of Cytek Biosciences?

Cytek Biosciences’s largest shareholders are Blackrock funding, inc. /de (18.48M shares, 14.11%), Blackrock (17.07M shares, 13.04%), and Vanguard group (11.72M shares, 8.94%). Together, they hold 36.09% of Cytek Biosciences’s total shares outstanding.

Does Blackrock own Cytek Biosciences?

Yes, BlackRock owns 13.04% of Cytek Biosciences, totaling 17.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 95.25M$. In the last quarter, BlackRock decreased its holdings by -356K shares, a -2.04% change.

Who is Cytek Biosciences’s biggest shareholder by percentage of total assets invested?

Hhlr advisors is Cytek Biosciences’s biggest shareholder by percentage of total assets invested, with 1.50% of its assets in 6.66M Cytek Biosciences shares, valued at 43.2M$.

Who is the top mutual fund holder of Cytek Biosciences shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Cytek Biosciences shares, with 5.16% of its total shares outstanding invested in 6.61M Cytek Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools